EP1333862A4 - Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons - Google Patents

Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons

Info

Publication number
EP1333862A4
EP1333862A4 EP01978796A EP01978796A EP1333862A4 EP 1333862 A4 EP1333862 A4 EP 1333862A4 EP 01978796 A EP01978796 A EP 01978796A EP 01978796 A EP01978796 A EP 01978796A EP 1333862 A4 EP1333862 A4 EP 1333862A4
Authority
EP
European Patent Office
Prior art keywords
embryos
establishment
compositions
improving
pharmaceutical methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01978796A
Other languages
German (de)
English (en)
Other versions
EP1333862A2 (fr
Inventor
Oron Yacoby-Zeevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Biopharmaceuticals Ltd
Original Assignee
Insight Strategy and Marketing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Strategy and Marketing Ltd filed Critical Insight Strategy and Marketing Ltd
Publication of EP1333862A2 publication Critical patent/EP1333862A2/fr
Publication of EP1333862A4 publication Critical patent/EP1333862A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01978796A 2000-10-17 2001-10-15 Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons Withdrawn EP1333862A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24085700P 2000-10-17 2000-10-17
US240857P 2000-10-17
PCT/IL2001/000950 WO2002032283A2 (fr) 2000-10-17 2001-10-15 Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons

Publications (2)

Publication Number Publication Date
EP1333862A2 EP1333862A2 (fr) 2003-08-13
EP1333862A4 true EP1333862A4 (fr) 2004-08-18

Family

ID=22908221

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01978796A Withdrawn EP1333862A4 (fr) 2000-10-17 2001-10-15 Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons

Country Status (3)

Country Link
EP (1) EP1333862A4 (fr)
AU (1) AU2002210887A1 (fr)
WO (1) WO2002032283A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
CA2432157A1 (fr) * 2000-12-19 2002-06-27 Insight Strategy And Marketing Ltd. Utilisation d'enzymes de degradation de l'ecm en vue de l'amelioration de greffes de cellules
CN100384481C (zh) * 2004-11-03 2008-04-30 上海市计划生育科学研究所 胚泡着床相关因子及其用途
CN100415299C (zh) * 2004-12-22 2008-09-03 上海市计划生育科学研究所 胚泡着床相关因子及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002977A1 (fr) * 1989-08-23 1991-03-07 Hadassah Medical Organization Preparations de cicatrisations de blessures contenant de l'heparanase
WO1999011798A1 (fr) * 1997-09-02 1999-03-11 Insight Strategy & Marketing Ltd. Polynucleotide codant pour un polypeptide presentant une activite d'heparanase et son expression par des cellules transductees
WO1999021975A1 (fr) * 1997-10-28 1999-05-06 The Australian National University Molecule isolee d'acide nucleique codant une endoglucuronidase mammalienne et ses applications
WO2000052149A1 (fr) * 1999-03-02 2000-09-08 Insight Strategy & Marketing Ltd. Administration d'un materiau biologique a un patient

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002977A1 (fr) * 1989-08-23 1991-03-07 Hadassah Medical Organization Preparations de cicatrisations de blessures contenant de l'heparanase
US5362641A (en) * 1989-08-23 1994-11-08 Hadassah Medical Organization Kiryat Hadassah Heparanase derived from human Sk-Hep-1 cell line
WO1999011798A1 (fr) * 1997-09-02 1999-03-11 Insight Strategy & Marketing Ltd. Polynucleotide codant pour un polypeptide presentant une activite d'heparanase et son expression par des cellules transductees
WO1999021975A1 (fr) * 1997-10-28 1999-05-06 The Australian National University Molecule isolee d'acide nucleique codant une endoglucuronidase mammalienne et ses applications
WO2000052149A1 (fr) * 1999-03-02 2000-09-08 Insight Strategy & Marketing Ltd. Administration d'un materiau biologique a un patient

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CARSON DANIEL D ET AL: "Mucin and proteoglycan functions in embryo implantation", BIOESSAYS, vol. 20, no. 7, July 1998 (1998-07-01), pages 577 - 583, XP002284179, ISSN: 0265-9247 *
DEMPSEY L A ET AL: "Heparanase expression in invasive trophoblasts and acute vascular damage", GLYCOBIOLOGY, IRL PRESS,, GB, vol. 10, no. 5, May 2000 (2000-05-01), pages 467 - 475, XP002232893, ISSN: 0959-6658 *
DEMPSEY L A ET AL: "Heparanase, a potential regulator of cell-matrix interactions.", TRENDS IN BIOCHEMICAL SCIENCES. ENGLAND AUG 2000, vol. 25, no. 8, August 2000 (2000-08-01), pages 349 - 351, XP004215172, ISSN: 0968-0004 *
VLODAVSKY I ET AL: "EXPRESSION OF HEPARANASE BY PLATELETS AND CIRCULATING CELLS OF THE IMMUNE SYSTEM: POSSIBLE INVOLVEMENT IN DIAPEDESIS AND EXTRAVASATION", INVASION METASTASIS, S. KARGER, BASEL, CH, vol. 12, no. 2, March 1992 (1992-03-01), pages 112 - 127, XP001106180, ISSN: 0251-1789 *

Also Published As

Publication number Publication date
AU2002210887A1 (en) 2002-04-29
WO2002032283A2 (fr) 2002-04-25
EP1333862A2 (fr) 2003-08-13
WO2002032283A3 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
EP1337249A4 (fr) Compositions et procedes pour l'administration de composes pharmacologiquement actifs
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
DE60023268D1 (de) INHIBITEURS PURIQUES DE KINASE 2 DEPENDANTE DES CYCLINES et IkB-alpha
FR14C0080I2 (fr) Methode d'administration d'un anticorps
EP1443905A4 (fr) Compositions pour therapie genique orale et procedes d'utilisation associes
MA26618A1 (fr) Composes et compositions pharmaceutiques pour le traitement du paludisme
DZ3391A1 (fr) Compositions pharmaceutiques d'inhibiteurs de proteine de transfert d'ester de cholesteryle
EE05585B1 (et) Indasoolihendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ning nende kasutamine
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
EP1416961A4 (fr) Composition et procede pour le traitement d'une maladie
EP1346724A4 (fr) Remedes pour l'hepatite c
NO20026209L (no) Endoparasitticidale midler for frivillig oralt inntak av dyr
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
NO20002686L (no) Forbedring av Peyronies sykdom
MA25234A1 (fr) Vibromasseur pour le soulagement des maux et de la douleur.
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
FR2802423B1 (fr) Compositions pharmaceutiques
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
EP1161255A4 (fr) Procedes et compositions pour le traitement de la dyserection
EP1333862A4 (fr) Procedes et compositions pharmaceutiques pour ameliorer l'implantation d'embryons
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
NO20020369L (no) Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer
EP1411897A4 (fr) Compositions et methodes d'administration intracellulaire
EP1163340A4 (fr) Compositions et methodes de modification de l'expression genique
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030513

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07H 21/04 B

Ipc: 7C 07H 21/02 B

Ipc: 7C 12N 15/86 B

Ipc: 7C 12N 15/85 B

Ipc: 7C 12N 15/11 B

Ipc: 7A 61K 38/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040701

17Q First examination report despatched

Effective date: 20050329

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INSIGHT BIOPHARMACEUTICALS LTD.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080411